Skip to main content

Advertisement

SpringerLink
Log in

Genetic association between ERCC5 rs17655 polymorphism and lung cancer risk: evidence based on a meta-analysis

  • Research Article
  • Published:
Tumor Biology

Abstracts

The relationship between excision repair cross-complementing group 5 (ERCC5) rs17655 polymorphism and lung cancer risk remains controversial. To clarify the association, we conducted a comprehensive meta-analysis of all published case–control studies. PubMed, Web of Science, and CNKI were searched to identify the possibly eligible publications. Pooled odds ratio (OR) was estimated using the fixed effect model. Q test and I 2 index were used to evaluate heterogeneity between studies, and Egger’s and Begg’s tests were utilized to assess publication bias. Meta-analysis of nine case–control studies including 4,044 cases and 5,100 controls indicated that there was no global association between rs17655 polymorphism and lung cancer risk. Subgroup analyses according to ethnicity and histologic type revealed similar results. In summary, our meta-analysis suggests that ERCC5 rs17655 polymorphism may not contribute to genetic susceptibility for lung cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Wood RD et al. Human DNA repair genes. Science. 2001;291(5507):1284–9.

    Article  CAS  PubMed  Google Scholar 

  2. Bernstein C et al. DNA repair/pro-apoptotic dual-role proteins in five major DNA repair pathways: fail-safe protection against carcinogenesis. Mutat Res. 2002;511(2):145–78.

    Article  CAS  PubMed  Google Scholar 

  3. Yu Z et al. Human DNA repair systems: an overview. Environ Mol Mutagen. 1999;33(1):3–20.

    Article  CAS  PubMed  Google Scholar 

  4. Thompson LH, West MG. XRCC1 keeps DNA from getting stranded. Mutat Res. 2000;459(1):1–18.

    Article  CAS  PubMed  Google Scholar 

  5. Chyou PH, Nomura AM, Stemmermann GN. A prospective study of the attributable risk of cancer due to cigarette smoking. Am J Public Health. 1992;82(1):37–40.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  6. Abbasi R et al. Laryngeal cancer risk associated with smoking and alcohol consumption is modified by genetic polymorphisms in ERCC5, ERCC6 and RAD23B but not by polymorphisms in five other nucleotide excision repair genes. Int J Cancer. 2009;125(6):1431–9.

    Article  CAS  PubMed  Google Scholar 

  7. Blomquist TM, Crawford EL, Willey JC. Cis-acting genetic variation at an E2F1/YY1 response site and putative p53 site is associated with altered allele-specific expression of ERCC5 (XPG) transcript in normal human bronchial epithelium. Carcinogenesis. 2010;31(7):1242–50.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  8. Wei Q et al. Reduced DNA repair capacity in lung cancer patients. Cancer Res. 1996;56(18):4103–7.

    CAS  PubMed  Google Scholar 

  9. Crawford EL et al. CEBPG regulates ERCC5/XPG expression in human bronchial epithelial cells and this regulation is modified by E2F1/YY1 interactions. Carcinogenesis. 2007;28(12):2552–9.

    Article  CAS  PubMed  Google Scholar 

  10. Emmert S et al. The human XPG gene: gene architecture, alternative splicing and single nucleotide polymorphisms. Nucleic Acids Res. 2001;29(7):1443–52.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  11. Kumar R et al. Single nucleotide polymorphisms in the XPG gene: determination of role in DNA repair and breast cancer risk. Int J Cancer. 2003;103(5):671–5.

    Article  CAS  PubMed  Google Scholar 

  12. Narter KF et al. Bladder cancer and polymorphisms of DNA repair genes (XRCC1, XRCC3, XPD, XPG, APE1, hOGG1). Anticancer Res. 2009;29(4):1389–93.

    CAS  PubMed  Google Scholar 

  13. Ma H et al. Polymorphisms of XPG/ERCC5 and risk of squamous cell carcinoma of the head and neck. Pharmacogenet Genomics. 2012;22(1):50–7.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  14. Pardini B et al. DNA repair genetic polymorphisms and risk of colorectal cancer in the Czech Republic. Mutat Res. 2008;638(1–2):146–53.

    Article  CAS  PubMed  Google Scholar 

  15. Jeon HS et al. Relationship between XPG codon 1104 polymorphism and risk of primary lung cancer. Carcinogenesis. 2003;24(10):1677–81.

    Article  CAS  PubMed  Google Scholar 

  16. Cui Y et al. Polymorphism of xeroderma pigmentosum group G and the risk of lung cancer and squamous cell carcinomas of the oropharynx, larynx and esophagus. Int J Cancer. 2006;118(3):714–20.

    Article  CAS  PubMed  Google Scholar 

  17. Sakiyama T et al. Association of amino acid substitution polymorphisms in DNA repair genes TP53, POLI, REV1 and LIG4 with lung cancer risk. Int J Cancer. 2005;114(5):730–7.

    Article  CAS  PubMed  Google Scholar 

  18. Zhu ML et al. Association between the ERCC5 Asp1104His polymorphism and cancer risk: a meta-analysis. PLoS One. 2012;7(7):e36293.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  19. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21(11):1539–58.

    Article  PubMed  Google Scholar 

  20. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959;22(4):719–48.

    CAS  PubMed  Google Scholar 

  21. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7(3):177–88.

    Article  CAS  PubMed  Google Scholar 

  22. Egger M et al. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629–34.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  23. Liang Gang LD. Polymorphisms in DNA repair genes and susceptibility to lung cancer, [doctoral dissertation]. China Xiehe Medical University, 2004: p. 1–122. cdmd.cnki.com.cn/Article/CDMD-10023-2006147134.htm.

  24. Shen M et al. Polymorphisms in the DNA nucleotide excision repair genes and lung cancer risk in Xuan Wei, China. Int J Cancer. 2005;116(5):768–73.

    Article  CAS  PubMed  Google Scholar 

  25. Chang JS et al. Nucleotide excision repair genes and risk of lung cancer among San Francisco Bay Area Latinos and African Americans. Int J Cancer. 2008;123(9):2095–104.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  26. Sakoda LC et al. Germ line variation in nucleotide excision repair genes and lung cancer risk in smokers. Int J Mol Epidemiol Genet. 2012;3(1):1–17.

    PubMed Central  CAS  PubMed  Google Scholar 

  27. Zeng Hong KM. Associations of XPA A23G and XPG His1104Asp polymorphisms with susceptibility to lung cancer. Guangdong Medical Journal. 2013;34(3):413–6.

    Google Scholar 

  28. Bernig T, Chanock SJ. Challenges of SNP genotyping and genetic variation: its future role in diagnosis and treatment of cancer. Expert Rev Mol Diagn. 2006;6(3):319–31.

    Article  CAS  PubMed  Google Scholar 

  29. Weiss JM et al. Nucleotide excision repair genotype and the incidence of endometrial cancer: effect of other risk factors on the association. Gynecol Oncol. 2006;103(3):891–6.

    Article  CAS  PubMed  Google Scholar 

  30. Koeppel F et al. Irofulven cytotoxicity depends on transcription-coupled nucleotide excision repair and is correlated with XPG expression in solid tumor cells. Clin Cancer Res. 2004;10(16):5604–13.

    Article  CAS  PubMed  Google Scholar 

  31. Cheng L et al. Expression of nucleotide excision repair genes and the risk for squamous cell carcinoma of the head and neck. Cancer. 2002;94(2):393–7.

    Article  CAS  PubMed  Google Scholar 

  32. Bartolucci R et al. XPG mRNA expression levels modulate prognosis in resected non-small-cell lung cancer in conjunction with BRCA1 and ERCC1 expression. Clin Lung Cancer. 2009;10(1):47–52.

    Article  CAS  PubMed  Google Scholar 

  33. Hung RJ et al. International Lung Cancer Consortium: pooled analysis of sequence variants in DNA repair and cell cycle pathways. Cancer Epidemiol Biomarkers Prev. 2008;17(11):3081–9.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  34. Wakasugi M, Sancar A. Order of assembly of human DNA repair excision nuclease. J Biol Chem. 1999;274(26):18759–68.

    Article  CAS  PubMed  Google Scholar 

Download references

Conflicts of interest

None

Author information

Authors and Affiliations

  1. Department of Respiratory Medicine, Affiliated Hospital of Luzhou Medical College, Luzhou, 646000, Sichuan Province, People’s Republic of China

    Yujia Liang, Jun Deng, Ying Xiong & Songping Wang

  2. Department of Respiratory Medicine, Southwest Hospital, Third Military Medical University, 29 Gaotanyan Main Street, Chongqing, 400038, People’s Republic of China

    Wei Xiong

Authors
  1. Yujia Liang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jun Deng
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ying Xiong
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Songping Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Wei Xiong
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Wei Xiong.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Liang, Y., Deng, J., Xiong, Y. et al. Genetic association between ERCC5 rs17655 polymorphism and lung cancer risk: evidence based on a meta-analysis. Tumor Biol. 35, 5613–5618 (2014). https://doi.org/10.1007/s13277-014-1742-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13277-014-1742-2

Keywords

Search

Navigation